The effectiveness of ribavirin in the treatment of RSV

Cooper discusses whether ribavarin is more effective than a placebo in improving the treatment outcomes of children with respiratory syncytial virus (RSV) pneumonia, based on four studies. Ribavirin appears to have little benefit in the treatment of severe LRTI caused by RSV.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pediatric nursing 2001-01, Vol.27 (1), p.95-98
1. Verfasser:	Cooper, K E
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiviral agents Antiviral Agents - therapeutic use Attrition (Research Studies) Care and treatment Causes of Children Children & youth Clinical outcomes Clinical Trials as Topic Drug therapy Evidence-Based Medicine Experimental Groups Guidelines Health aspects Humans Libraries Mortality Rate Nursing Outcome Measures Outcomes of Treatment Patients Physicians Pneumonia Respiratory diseases Respiratory syncytial virus infection Respiratory Syncytial Virus Infections - drug therapy Respiratory tract infections Ribavirin Ribavirin - therapeutic use Statistical Analysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Cooper discusses whether ribavarin is more effective than a placebo in improving the treatment outcomes of children with respiratory syncytial virus (RSV) pneumonia, based on four studies. Ribavirin appears to have little benefit in the treatment of severe LRTI caused by RSV.
ISSN:	0097-9805